efectin ep 37,5 mg
pfizer europe ma eeig - venlafaxinum - caps. elib. prel. - 37,5 mg - antidepresive alte antidepresive
efectin ep 75 mg
pfizer europe ma eeig - venlafaxinum - caps. elib. prel. - 75 mg - antidepresive alte antidepresive
efectin ep 150 mg
pfizer europe ma eeig - venlafaxinum - caps. elib. prel. - 150 mg - antidepresive alte antidepresive
harmonet 0,075 mg/0,020 mg
pfizer europe ma eeig - combinatii (gestodenum+etinilestradiolum) - draj. - 0,075mg/0,020mg - contraceptive hormonale sistemice progesteroni si estrogeni combinatii fixe
atorvastatin pfizer 10 mg
pfizer manufacturing deutschland gmbh - germania - atorvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
atorvastatin pfizer 20 mg
pfizer manufacturing deutschland gmbh - germania - atorvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
atorvastatin pfizer 40 mg
pfizer manufacturing deutschland gmbh - germania - atorvastatinum - compr. film. - 40mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
atorvastatin pfizer 80 mg
pfizer manufacturing deutschland gmbh - germania - atorvastatinum - compr. film. - 80mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacteriene pentru uz sistemic, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. trebuie luate în considerare ghidurile oficiale referitoare la utilizarea adecvată a medicamentelor antibacteriene.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacteriene pentru uz sistemic, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.